XML 119 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Operating activities    
Net income $ 43,044 $ 46,199
Adjustments to reconcile net income to cash used in operating activities:    
Depreciation and amortization 28,184 22,500
Bad debt expense 610 493
Cash distributions (less than) in excess of income of unconsolidated affiliates (4,333) 9,451
Gains and amortization of deferred gains on sales of railcars and related leases (14,616) (8,674)
Excess Tax Benefit from Share-based Compensation, Operating Activities 278 35
Deferred income taxes 22,525 4,399
Stock based compensation expense 1,435 2,875
Other 714 62
Changes in operating assets and liabilities:    
Accounts receivable (7,517) (36,277)
Inventories 331,596 176,766
Commodity derivatives 12,770 (27,790)
Other assets 7,017 1,624
Accounts payable for grain (404,636) (261,925)
Other accounts payable and accrued expenses (76,184) (63,758)
Net cash used in operating activities (59,669) (134,090)
Investing Activities    
Purchase of investments 0 (19,996)
Proceeds from redemption of investment 0 19,998
Acquisition of businesses, net of cash acquired (3,345) (93,112)
Purchases of railcars (56,899) (77,028)
Proceeds from sale of railcars 53,243 16,057
Purchases of property, plant and equipment (18,549) (38,171)
Proceeds from sale of property, plant and equipment 137 725
Proceeds from minority investor 0 6,100
Change in restricted cash (474) 13,007
Net cash used in investing activities (25,887) (172,420)
Financing Activities    
Net change in short-term borrowings 25,781 238,108
Proceeds from issuance of long-term debt 36,391 106,878
Payments of long-term debt (34,708) (30,675)
Proceeds from sale of treasury shares to employees and directors 1,547 1,350
Payment of debt issuance costs (46) (72)
Dividends paid (5,985) (5,574)
Excess Tax Benefit (Tax Deficiency) from Share-based Compensation, Financing Activities 278 35
Net cash provided by financing activities 23,258 310,050
Increase (decrease) in cash and cash equivalents (62,298) 3,540
Cash and cash equivalents at beginning of period 138,218 20,390
Cash and cash equivalents at end of period 75,920 23,930
Supplemental disclosure of cash flow information    
Capitalized software costs incurred but not yet paid 3,839 0
Purchase of capitalized software through seller-financing $ 9,393 $ 0